Sesen Bio Inc (NASDAQ:SESN)
| 0.8904 Delayed Data As of Jan 24 |  -0.0392 / -4.22%Today’s Change | 0.69 Today|||52-Week Range 2.60 | -14.38% Year-to-Date |
Latest SESN News | Press Releases
No recent news for Sesen Bio Inc.
Today’s Trading
| Previous close | 0.93 |
| Today’s open | 0.94 |
| Day’s range | 0.88 - 0.95 |
| Volume | 1,187,366 |
| Average volume (3 months) | 1,404,286 |
| Market cap | $175.9M |
Data as of 4:00pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | +50.86% |
| Earnings growth (this year) | -66.06% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TRVITrevi Therapeutics I... | +0.19 | +3.81% |
| SCYXSCYNEXIS Inc | +0.01 | +0.52% |
| AVEOAveo Pharmaceuticals... | -0.01 | -2.15% |
| ASRTAssertio Therapeutic... | -0.05 | -4.27% |
Data as of 4:00pm ET, 01/24/2020
Financials
| Next reporting date | March 10, 2020 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
